Loading
Life sciences · Journal article
Diagnostics · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background/Objectives: Radioactive iodine (RAI) therapy is widely used after thyroidectomy for differentiated thyroid cancer, but early renal tubular changes may not be reflected by conventional renal function parameters. We prospectively evaluated urinary tubular biomarker changes across three administered RAI activities. Methods: We included 120 patients, with 40 in each activity group (1.11, 3.70, and 5.55 GBq). Blood was collected at baseline and day 7, and urine at baseline, day 1, and day 7. Urinary kidney injury molecule-1, netrin-1, cystatin C, and β2-microglobulin were measured by enzyme-linked immunosorbent assay; conventional renal parameters were also assessed. Results: All four biomarkers increased significantly from baseline to Day 1 in all activity groups. Percentage increases were numerically greater at higher administered activities; however, baseline-adjusted mixed-effects analysis showed no significant activity-group effect or activity group × time interaction. Absolute biomarker levels partially declined by Day 7 and remained numerically above baseline, whereas urinary creatinine-normalized biomarker ratios remained significantly elevated. Serum creatinine decreased and creatinine-based eGFR increased by Day 7, whereas urinary albumin, protein, and phosphate showed no consistent changes across the activity groups. Conclusions: The concordant early changes observed in urinary tubular biomarkers, without deterioration in conventional renal function parameters, support an early subclinical tubular response following RAI therapy. Although percentage increases were numerically greater at higher administered activities, baseline-adjusted mixed-effects analyses did not support an independent activity-related effect. Therefore, these findings should not be interpreted as evidence of clinically significant renal injury. Longer-term studies are needed to determine the persistence, reversibility, and clinical significance of these findings.